It appears Dracula may have been onto something when he drank the blood of young maidens.
Scores of start-ups have been tinkering with transfusions of blood from younger adults to treat age-related diseases.
But a leading geneticist at University College London insists those experiments are no joke, and are seriously considered by leading physicians to be one of the most promising ventures in modern medicine.
Publishing an analysis of data in the journal Nature, Dame Linda Partridge, a geneticist, says research shows young blood could allow humans to live a life free of diseases like cancer, dementia and heart disease, right up until their deaths.
Her work forms part of a wave of studies and trials, including a set of human trials backed by Peter Thiel at a San Francisco start-up called Ambrosia, injecting older adults with young blood – something that would cost $8,000 if it were rolled out to the public.
Read more HERE